Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Dec:13:100318.
doi: 10.1016/j.onehlt.2021.100318. Epub 2021 Aug 26.

Evidence of neutralizing antibodies against SARS-CoV-2 in domestic cats living with owners with a history of COVID-19 in Lima - Peru

Affiliations

Evidence of neutralizing antibodies against SARS-CoV-2 in domestic cats living with owners with a history of COVID-19 in Lima - Peru

Luis M Jara et al. One Health. 2021 Dec.

Abstract

SARS-CoV-2 can infect a variety of wild and domestic animals worldwide. Of these, domestic cats are highly susceptible species and potential viral reservoirs. As such, it is important to investigate disease exposure in domestic cats in areas with active community transmission and high disease prevalence. In this report we demonstrate the presence of serum neutralizing antibodies against the receptor binding-domain (RBD) of the SARS-CoV-2 in cats whose owners had been infected with SARS-CoV-2 in Lima, Peru, using a commercial competitive ELISA SARS-CoV-2 Surrogate Virus Neutralization Test. Out of 41 samples, 17.1% (7/41) and 31.7% (13/41) were positive, using the cut-off inhibition value of 30% and 20%, respectively. Not all cats living in a single house had detectable neutralizing antibodies showing heterogenous exposure and immunity among cohabiting animals. This is the first report of SARS-COV-2 exposure of domestic cats in Lima, Peru. Further studies are required to ascertain the prevalence of SARS-COV-2 exposure among domestic cats.

Keywords: COVID-19; Cats; Neutralizing antibodies; One health; SARS-CoV-2; Serology.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Percent inhibition against SARS-COV-2 receptor binding-domain (RBD) in serum of domestic cats whose owners had a history of COVID-19 (n = 41). C: controls, (−): negative, (+): positive. The 17.1% (7/41) and 31.7% (13/41) shows the frequency of cats with neutralizing antibodies with 30% and 20% of cut-off values of inhibition, respectively.

Update of

References

    1. Bertzbach L.D., Vladimirova D., Dietert K., Abdelgawad A., Gruber A.D., Osterrieder N., Trimpert J. SARS-CoV-2 infection of Chinese hamsters (Cricetulus griseus) reproduces COVID-19 pneumonia in a well-established small animal model. Transbound. Emerg. Dis. 2021;68:1075–1079. doi: 10.1111/tbed.13837. - DOI - PMC - PubMed
    1. Mahdy M.A.A., Younis W., Ewaida Z. An overview of SARS-CoV-2 and animal infection. Front. Vet. Sci. 2020;7:596391. doi: 10.3389/fvets.2020.596391. - DOI - PMC - PubMed
    1. Munnink B.B. Oude, Sikkema R.S., Nieuwenhuijse D.F., Molenaar R.J., Munger E., Molenkamp R., van der Spek A., Tolsma P., Rietveld A., Brouwer M., Bouwmeester-Vincken N., Harders F., der Honing R. Hakze-van, Wegdam-Blans M.C.A., Bouwstra R.J., GeurtsvanKessel C., van der Eijk A.A., Velkers F.C., Smit L.A.M., Stegeman A., van der Poel W.H.M., Koopmans M.P.G. Transmission of SARS-CoV-2 on mink farms between humans and mink and back to humans. Science. 2021;371:172–177. doi: 10.1126/science.abe5901. - DOI - PMC - PubMed
    1. Shi J., Wen Z., Zhong G., Yang H., Wang C., Huang B., Liu R., He X., Shuai L., Sun Z., Zhao Y., Liu P., Liang L., Cui P., Wang J., Zhang X., Guan Y., Tan W., Wu G., Chen H., Bu Z. Susceptibility of ferrets, cats, dogs, and other domesticated animals to SARS-coronavirus 2. Science. 2020;368:1016–1020. doi: 10.1126/science.abb7015. - DOI - PMC - PubMed
    1. Sit T.H.C., Brackman C.J., Ip S.M., Tam K.W.S., Law P.Y.T., E.M.W. To, Yu V.Y.T., Sims L.D., Tsang D.N.C., Chu D.K.W., Perera R.A.P.M., Poon L.L.M., Peiris M. Infection of dogs with SARS-CoV-2. Nature. 2020;586:776–778. doi: 10.1038/s41586-020-2334-5. - DOI - PMC - PubMed